TABLE 2.
Intraoperative results, early and long term outcomes.
All, n = 66 | Septal thickness < 18 mm (n = 29) | Septal thickness ≥ 18 mm (n = 37) | P-value | |
Aortic cross-clamp (min) | 41.4 ± 10.6 (20–80) | 41.9 ± 10.9 (20–65) | 41.1 ± 10.6 (24–80) | 0.7 |
Cardiopulmonary bypass (min) | 56.5 ± 12.7 (25–105) | 56.8 ± 13.7 (25–88) | 56.2 ± 12.1 (38–105) | 0.8 |
Resected cords (n) | 3.5 ± 1.6 (0–8) | 3.5 ± 1.6 (0–8) | 3.5 ± 1.6 (0–7) | 0.9 |
Procedures on papillary muscles (n) | 1.3 ± 0.8 (0–3) | 1.4 ± 0.9 (0–3) | 1.2 ± 0.8 (0–2) | 0.4 |
Mitral valve replacement | 2 (3) | 0 | 2 (3) | 0.4 |
Intraoperative mitral valve replacement for MR | 1 (1) | 0 | 1 (1) | 0.4 |
Posterior mitral leaflet shortening | 4 (6) | 4 (6) | 0 (0) | 0.033 |
Other procedures | 6 (9) | 4 (6) | 2 (3) | 0.3 |
Blood transfusion | 37 (56) | 17 (25) | 20 (30) | 0.8 |
Re-exploration | 1 (1) | 1 (1) | 0 (0) | 0.4 |
Low cardiac output syndrome | 2 (3) | 1 (1) | 1 (1) | 1 |
Sepsis | 3 (4) | 1 (1) | 2 (3) | 1 |
Post-operative atrial fibrillation | 33 (50) | 11 (16) | 22 (34) | 0.1 |
Post-operative PM implantation | 3 (4) | 2 (3) | 1 (1) | 0.5 |
Post-operative Complete AV block | 0 | |||
Iatrogenic ventricular septal defect | 0 | |||
Length of stay (days) | 10.6 ± 8.3 (5–62) | 10.1 ± 6 (5–33) | 10.9 ± 9.8 (5–62) | 1 |
Pre-discharge SAM | 2 (3) | 1 (1) | 1 (1) | 1 |
Pre-discharge | ||||
LVOT gradient* (mmHg) | 15.4 ± 8.5 (0–33) | 14.7 ± 8 (0–30) | 16 ± 8.8 (0–33) | 0.5 |
Septal thickness (mm) | 14 ± 2.6 (7–16) | 12.7 ± 1.4 (10–16) | 15 ± 2.9 (7–16) | 0.0001 |
NYHA functional class | 1.3 ± 0.5 (1–3) | 0.7 | ||
I–II | 63 (95) | 27 (41) | 36 (55) | 0.7 |
III | 3 (5) | 2 (3) | 1 (1) | |
MR grade | 1.2 ± 0.6 (0–3) | 0.2 | ||
≤ 1 + /4 + | 50 (75) | 25 (37.5) | 25 (37.5) | |
2 + /4 + | 15 (22) | 4 (6) | 11 (16) | |
3 + /4 + | 1 (3) | 0 | 1 (3) | |
Hospital mortality | 0 | |||
Follow-up | ||||
SAM | 7 (11) | 2 (3) | 5 (8) | 0.5 |
LVOT gradient* (mmHg) | 16.3 ± 8.8 (6–40) | 18.2 ± 9.2 (6–40) | 14.8 ± 8.2 (8–39) | 0.1 |
Septal thickness (mm) | 13.9 ± 2.7 (9–16) | 12.9 ± 1.9 (10–18) | 14.8 ± 3 (9–16) | 0.0068 |
NYHA functional class | 1.6 ± 0.6 (1–3) | 0.9 | ||
I | 27 (43) | 11 (17) | 16 (25) | |
II | 35 (54) | 16 (25) | 19 (29) | |
III | 2 (3) | 1 (1) | 1 (1) | |
MR grade | 1.2 ± 0.5 (0–4) | 0.6 | ||
≤ 2 + /4 + | 62 (98) | 28 (44) | 34 (54) | |
4 + /4 + | 1 (2) | 0 | 1 (1) | |
Reoperation at follow-up for MR | 0 | |||
Exitus at follow-up | 2 (3) | 1 (1.5) | 1 (1.5) | 1 |
MR, mitral regurgitation; PM, pacemaker; AV, atrio-ventricular; SAM, systolic anterior motion. LVOT, left ventricle outflow tract; NYHA, New York Heart Association.
*Peak gradient at rest.
Continuous variables were expressed as mean, standard deviation and range.
Categorical variables were expressed as absolute value and percentage.
Bold values are referred to the significative p value.